Krebs Biochemicals & Industries Ltd leads gainers in ‘B’ group
3 months ago•Business Standard
Kilitch Drugs Standalone March 2022 Net Sales at Rs 32.03 crore, up 51.49% Y-o-Y
2 years ago•Moneycontrol
Kilitch Drugs commences Rs100 crore new facility expansion plan
2 years ago•India Infoline
Kilitch Drugs (India) reports standalone net profit of Rs 2.89 crore in the June 2021 quarter
3 years ago•Business Standard
Kilitch Drugs starts production of Cephalosporin Injectables at Ethiopia Plant; Stock surges 5%
3 years ago•India Infoline
Kilitch Drugs (India) reports consolidated net profit of Rs 0.71 crore in the March 2021 quarter
3 years ago•Business Standard
Buzzing Stocks | Bharti Airtel, RIL, Railtel, Bank Of Maharashtra, Equitas Holdings, Tata Chemicals, Hindustan Aeronautics
3 years ago•Moneycontrol